Amgen CFO Peter Griffith retiring; Thomas Dittrich to succeed September 1, 2026

AMGEN INC

Peter Griffith retiring as EVP/CFO effective Aug 31, 2026; stays as non-executive EVP through Jan 2027.
Thomas Dittrich appointed EVP/CFO effective Sep 1, 2026; returns to Amgen after CFO roles at Galderma, Shire, Sulzer.
Dittrich receives CHF 1.07M base salary, CHF 4.5M LTI target, one-time RSU of CHF 4.7M and cash bonus of CHF 4M.
Dittrich to relocate from Switzerland to Thousand Oaks; receives relocation allowance of CHF 250K and standard severance.

item 5.02item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Peter H. Griffith

Executive Vice President and Chief Financial Officer

AMGN · AMGEN INC

Effective: 2026-08-31
Successor: Thomas Dittrich
Filed: May 19, 2026 20:08 UTC

On May 19, 2026, Amgen Inc. (the “Company”) publicly announced that Peter H. Griffith will retire from the role of the Company’s Executive Vice President and Chief Financial Officer, effective August 31, 2026.

Appointed

Thomas Dittrich

Executive Vice President and Chief Financial Officer

AMGN · AMGEN INC

Effective: 2026-09-01
Filed: May 19, 2026 20:08 UTC

Effective September 1, 2026, he will serve as Executive Vice President and Chief Financial Officer of the Company.

Source: SEC EDGAR

accession 0000318154-26-000097

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.